Group 1 - The total margin balance of the STAR Market reached 198.456 billion yuan on August 19, an increase of 3.524 billion yuan from the previous trading day [1] - The financing balance amounted to 197.839 billion yuan, increasing by 3.537 billion yuan, while the securities lending balance decreased by 0.013 billion yuan to 0.617 billion yuan [1] - A total of 382 STAR Market stocks experienced net financing inflows, with 21 stocks having net inflows exceeding 50 million yuan, led by Ying Shi Innovation with a net inflow of 287 million yuan [1] Group 2 - The Food and Beverage ETF (Product Code: 515170) tracks the CSI Sub-Industry Food and Beverage Theme Index [2] - Over the past five days, the ETF has seen a price change of 1.56% and has a price-to-earnings ratio of 20.35 times [2] - The latest share count for the ETF is 6.06 billion, with an increase of 99 million shares and a net inflow of 10.272 million yuan from major funds [2]

科创板个股中，截至发稿上涨的共有233只，涨幅在5%以上的共有21只，涨幅较高的有申联生物、芯原 股份、普元信息等，分别上涨20.03%、20.00%、14.13%，下跌的有347只，跌幅较大的有上纬新材、壹 石通、南模生物，分别下跌9.61%、7.35%、7.21%。 （原标题：芯原股份涨停 21只科创板股涨超5%） 8月19日盘中科创板股芯原股份涨停，截至10:43，股价报134.70元，成交23.43亿元，换手率3.81%，振 幅21.74%。 融资融券数据显示，该股最新（8月18日）两融余额为7.00亿元，其中，融资余额为6.88亿元，较上一个 交易日增加1435.01万元，增幅为2.13%；融券余额为1174.49万元，较上一个交易日减少207.22万元，降 幅为15.00%。近10日两融余额合计减少4907.13万元，降幅为6.55%，其间融资余额下降5.88%，融券余 额下降34.01%。 从机构评级来看，近一个月该股获3家机构买入评级。8月5日财通证券发布的研报给予公司增持评级。8 月5日民生证券发布的研报给予公司推荐评级。8月3日东吴证券发布的研报给予公司买入评级。（数据 宝） 注：本文系新 ...

Core Viewpoint - The article discusses the newly released "Guidelines for Self-Regulatory Supervision of Listed Companies on the Science and Technology Innovation Board No. 5 - Growth Layer" by the Shanghai Stock Exchange, focusing on the support for technology companies that are in the growth phase and currently unprofitable [3]. Summary by Sections Definition of Growth Layer Companies - The Growth Layer is designed to support technology companies that have significant technological breakthroughs, broad commercial prospects, and substantial ongoing R&D investments, but are still in an unprofitable stage at the time of listing [5]. Applicability of Growth Layer Companies - The Growth Layer applies to both existing unprofitable companies on the Science and Technology Innovation Board (referred to as "existing companies") and newly registered companies that are unprofitable at the time of listing (referred to as "incremental companies"). Existing companies will be included in the Growth Layer from the date of the guideline's release, while incremental companies will be included from the date of listing [6]. Conditions for Removal from the Growth Layer - The conditions for removal from the Growth Layer are defined as follows: 1. If a company has positive net profits for the last two years and a cumulative net profit of no less than 50 million yuan. 2. If a company has positive net profit for the last year and an operating income of no less than 100 million yuan. - For existing companies, the removal condition remains that they must achieve profitability for the first time after listing [8]. Investor Awareness of Removal - Investors can be informed about a company's removal from the Growth Layer through the annual report, where the company will disclose the conditions met for removal. The Shanghai Stock Exchange will also promptly announce the removal [9]. Special Marking for Growth Layer Stocks - Stocks or depositary receipts from the Growth Layer will have a special marking ("U") added to their names to indicate their status. Companies that fail to disclose annual reports or receive adverse audit opinions will not have their status adjusted [10]. Trading Considerations for Investors - Investors participating in trading of newly registered Growth Layer stocks must sign a special risk disclosure document. Existing stocks or depositary receipts are not subject to this requirement [12]. Information Disclosure Requirements - Companies in the Growth Layer are subject to stricter information disclosure requirements, including detailed explanations of their unprofitability and its impact in their annual reports. The lead underwriters are responsible for ongoing supervision and must report on any risks or negative events affecting the company's technological innovation and growth prospects [15][16].

8月19日开盘科创板股申联生物涨停，截至09:32，股价报14.80元，成交1.71亿元，换手率2.77%，振幅 8.50%。 融资融券数据显示，该股最新（8月18日）两融余额为1.03亿元，其中，融资余额为1.03亿元，较上一个 交易日增加458.94万元，增幅为4.67%；近10日两融余额合计减少925.83万元，降幅为8.26%，其间融资 余额下降8.26%。（数据宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 科创板个股中，截至发稿上涨的共有165只，涨幅在5%以上的共有8只，涨幅较高的有申联生物、影石 创新、腾景科技等，分别上涨15.35%、14.71%、12.29%，下跌的有411只，跌幅较大的有上纬新材、中 邮科技、芯动联科，分别下跌8.48%、7.14%、4.75%。 资金面上，申联生物上一交易日主力资金净流入2827.19万元，近5日净流入5436.15万元。 ...

融资融券数据显示，该股最新（8月15日）两融余额为4.42亿元，其中，融资余额为4.41亿元，较上一个 交易日增加4927.03万元，增幅为12.59%；融券余额为117.02万元，较上一个交易日增加6.30万元，增幅 为5.69%。近10日两融余额合计增加3057.80万元，增幅为7.44%，其间融资余额增长7.41%，融券余额增 长20.38%。（数据宝） （文章来源：证券时报网） 科创板个股中，截至发稿上涨的共有463只，涨幅在10%以上的共有17只，除天承科技之外，涨停的还 有申联生物、德科立、影石创新等，下跌的有119只，跌幅较大的有中邮科技、南模生物、康众医疗， 分别下跌6.89%、6.20%、5.98%。 资金面上，天承科技上一交易日主力资金净流入2243.11万元，近5日净流入2250.92万元。 8月18日盘中科创板股天承科技涨停，截至10:25，股价报96.77元，成交5.88亿元，换手率13.19%，振幅 8.33%。 ...

Group 1 - The stock of Ying Shi Innovation reached a limit-up on August 18, with a price of 269.30 yuan and a trading volume of 1.254 billion yuan, reflecting a turnover rate of 15.92% and a fluctuation of 8.52% [2] - Among the stocks on the Sci-Tech Innovation Board, 363 stocks were up, with 9 stocks rising over 10%, including Shenglian Biological, Ying Shi Innovation, and Nanya New Materials, which increased by 20.02%, 20.00%, and 16.83% respectively [2] - A total of 220 stocks were down, with significant declines in Zhongyou Technology, Helin Weina, and Nanmo Biological, which fell by 10.18%, 7.80%, and 6.73% respectively [2] Group 2 - On the funding side, Ying Shi Innovation saw a net inflow of 221 million yuan from main funds on the previous trading day, with a net inflow of 262 million yuan over the past five days [3] - As of August 15, the margin trading balance for the stock was 442 million yuan, with a financing balance of 442 million yuan, an increase of 49.119 million yuan from the previous trading day, representing a growth of 12.50% [3] - Over the past ten days, the total margin trading balance increased by 148 million yuan, reflecting a growth rate of 50.45%, with the financing balance also growing by 50.45% during this period [3] Group 3 - In terms of institutional ratings, Ying Shi Innovation received buy ratings from 8 institutions in the past month [3] - On August 15, Guosen Securities issued a report giving the company an outperform rating, while Huatai Securities set a target price of 197.64 yuan with an increase rating [3] - Huaxin Securities also issued a buy rating for the company on August 15 [3]

Group 1 - The core point of the news is the significant stock performance of Shenlian Biological on the STAR Market, with a notable increase in its stock price and trading volume [2] - As of August 18, Shenlian Biological's stock price reached 12.83 yuan, with a trading volume of 146 million yuan and a turnover rate of 2.79% [2] - Among STAR Market stocks, 460 stocks were reported to be rising, with 7 stocks increasing by over 10%, including Shenlian Biological, which rose by 20.02% [2] Group 2 - In terms of capital flow, Shenlian Biological experienced a net inflow of 54.32 million yuan from main funds on the previous trading day, with a total net inflow of 44.64 million yuan over the past five days [3] - The latest margin trading data as of August 15 shows that the margin balance for Shenlian Biological was 98.21 million yuan, with a decrease of 1.14% from the previous trading day [3] - Over the past ten days, the total margin balance decreased by 11.11 million yuan, reflecting a decline of 10.17% [3]

资金面上，中邮科技上一交易日主力资金净流出4013.15万元，近5日净流入8594.21万元。 融资融券数据显示，该股最新（8月14日）两融余额为2.50亿元，其中，融资余额为2.50亿元，较上一个 交易日增加737.75万元，增幅为3.04%；近10日两融余额合计增加3223.66万元，增幅为14.82%，其间融 资余额增长14.82%。 （文章来源：证券时报网） 8月15日尾盘科创板股中邮科技涨停，截至14:59，股价报75.71元，成交10.30亿元，换手率22.54%，振 幅19.51%。 科创板个股中，截至发稿上涨的共有543只，涨幅在10%以上的共有25只，除中邮科技之外，涨停的还 有杰华特、磁谷科技、均普智能等，下跌的有43只，跌幅较大的有麦澜德、德科立、凯立新材，分别下 跌7.28%、4.04%、3.90%。 ...

Core Viewpoint - The article discusses the newly released "Guidelines for Self-Regulatory Supervision of Listed Companies on the Science and Technology Innovation Board - Growth Layer" by the Shanghai Stock Exchange, which aims to support technology companies that are in the growth phase and still unprofitable at the time of listing [2]. Group 1: Definition and Target Companies - The Growth Layer is designed to support technology companies that have significant technological breakthroughs, broad commercial prospects, and substantial ongoing R&D investments, while still being in an unprofitable stage at the time of listing [4]. Group 2: Applicability of the Growth Layer - The Growth Layer applies to both existing unprofitable companies listed on the Science and Technology Innovation Board (referred to as "existing companies") and newly registered companies that are unprofitable at the time of listing (referred to as "incremental companies"). Existing companies will be included in the Growth Layer from the date of the guideline's release, while incremental companies will be included from the date of their listing [5]. Group 3: Conditions for Removal from the Growth Layer - The conditions for removal from the Growth Layer are defined as follows: 1. If a company has positive net profits for the last two years and a cumulative net profit of no less than 50 million yuan. 2. If a company has positive net profit for the last year and an operating income of no less than 100 million yuan. - For existing companies, the removal condition remains that they must achieve profitability after listing [7]. Group 4: Investor Awareness and Information Disclosure - Investors can be informed about a company's removal from the Growth Layer through the company's annual report, which will include an announcement if the company meets the removal conditions. The Shanghai Stock Exchange will also promptly update the status of the company [8]. - A special identifier "U" will be added to the stock or depositary receipt name to indicate that it is a Growth Layer stock. Companies that fail to disclose annual reports or receive negative audit opinions will not have their status adjusted [9]. Group 5: Trading Considerations for Investors - Investors participating in trading of newly registered Growth Layer stocks must sign a special risk disclosure document. However, existing stocks or depositary receipts are not affected by this requirement [11]. Group 6: Information Disclosure Requirements - The Shanghai Stock Exchange imposes stricter information disclosure requirements on Growth Layer companies, which must explain the reasons for their unprofitability and its impact in their annual reports. The sponsoring institutions must also fulfill their supervisory responsibilities and disclose any significant adverse risks related to the company's technological innovation and growth prospects [14][15].

8月14日盘中科创板股博拓生物涨停，截至11:07，股价报45.13元，成交3.89亿元，换手率6.29%，振幅 17.63%。 科创板个股中，截至发稿上涨的共有116只，涨幅在10%以上的共有6只，涨幅较高的有博拓生物、龙图 光罩、有方科技等，分别上涨19.99%、18.80%、13.31%，下跌的有468只，跌幅较大的有鼎阳科技、科 威尔、金橙子，分别下跌10.80%、8.13%、7.79%。 资金面上，博拓生物上一交易日主力资金净流出1033.96万元，近5日净流出1848.69万元。 融资融券数据显示，该股最新（8月13日）两融余额为1.88亿元，其中，融资余额为1.88亿元，较上一个 交易日减少1040.00万元，降幅为5.25%；近10日两融余额合计增加1.09万元，增幅为0.01%，其间融资 余额增长0.01%。（数据宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） ...